Central inflammation versus peripheral regulation in multiple sclerosis

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Neurology

• Publication date

  2011-03-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00415-011-5973-5PMID 21547381
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Th17/Th1 phenotype in demyelinating disease.

  2010cited by this paper
• Inflammatory Effects of Ex Vivo Human Th17 Cells Are Suppressed by Regulatory T Cells

  2010cited by this paper
• Preferential recruitment of interferon‐γ–expressing TH17 cells in multiple sclerosis

  2009cited by this paper
• The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy.

  2009cited by this paper
• Glucocorticoids increase CD4+CD25high cell percentage and Foxp3 expression in patients with multiple sclerosis

  2009cited by this paper
• Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.

  2009cited by this paper
• T‐helper 17 cells expand in multiple sclerosis and are inhibited by interferon‐β

  2009cited by this paper
• Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease

  2009cited by this paper
• The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells.

  2008cited by this paper
• Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients

  2008cited by this paper
• Cutting Edge: Th1 Cells Facilitate the Entry of Th17 Cells to the Central Nervous System during Experimental Autoimmune Encephalomyelitis1

  2008cited by this paper
• CD4+CD25+FoxP3+PD1— regulatory T cells in acute and stable relapsing‐remitting multiple sclerosis and their modulation by therapy

  2008cited by this paper
• Natural Naive CD4+CD25+CD127low Regulatory T Cell (Treg) Development and Function Are Disturbed in Multiple Sclerosis Patients: Recovery of Memory Treg Homeostasis during Disease Progression1

  2008cited by this paper
• Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

  2007cited by this paper
• IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: implications for their possible immunopathogenic roles.

  2006cited by this paper
• The interleukin-10 levels as a potential indicator of positive response to interferon beta treatment of multiple sclerosis patients.

  2006cited by this paper
• Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis

  2005cited by this paper
• Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3.

  2005cited by this paper
• Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients

  2005cited by this paper
• Decreased FOXP3 levels in multiple sclerosis patients

  2005cited by this paper
• IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.

  2004cited by this paper
• Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis

  2004cited by this paper
• Circulating CD4+CD25+ T Regulatory Cells Are Not Altered in Multiple Sclerosis and Unaffected by Disease-Modulating Drugs

  2004cited by this paper
• Multiple sclerosis: a study of chemokine receptors and regulatory T cells in relation to MRI variables

  2003cited by this paper
• Cerebrospinal fluid and serum protein levels of tumour necrosis factor-alpha (TNF-alpha) interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6R gp80) in multiple sclerosis patients.

  2002cited by this paper
• Serum cytokine levels do not correlate with disease activity and severity assessed by brain MRI in multiple sclerosis

  2002cited by this paper
• Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β

  2001cited by this paper
• Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood

  2001cited by this paper
• Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis.

  2000cited by this paper
• Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity.

  1998cited by this paper
• Serum interleukin-12 levels in patients with multiple sclerosis.

  1998cited by this paper
• Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis

  1996cited by this paper
• Evaluation of interleukin 10 and interferon‐α in the cerebrospinal fluid and serum of patients with multiple sclerosis

  1996cited by this paper
• Interleukin-6 family of cytokines and gp130.

  1995cited by this paper
• Serial gadolinium‐enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration

  1992cited by this paper
• In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis.

  1992cited by this paper
• Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis.

  1991cited by this paper
• Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis.

  1991cited by this paper
• Cytokine accumulations in CSF of multiple sclerosis patients

  1990cited by this paper

• THE action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis.

  2020cites this paper
• Depression and fatigue in multiple sclerosis: Relation to exposure to violence and cerebrospinal fluid immunomarkers.

  2018cites this paper
• Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+T lymphocytes of relapsing-remitting multiple sclerosis patients.

  2018cites this paper
• Psychiatric comorbidity in multiple sclerosis : biological and epidemiological aspects

  2017cites this paper
• Regulation is no bad thing

  2017cites this paper
• Peripheral Inflammation and Demyelinating Diseases.

  2016cites this paper
• BLOOD COUNT IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH MITOXANTRONE IN SHORT TIME OBSERVATION.

  2016cites this paper
• Parallel Aspects of the Microenvironment in Cancer and Autoimmune Disease

  2016cites this paper
• Chronic lung disease and multiple sclerosis: Incidence, prevalence, and temporal trends.

  2016cites this paper
• CD28 costimulatory signals in T lymphocyte activation: Emerging functions beyond a qualitative and quantitative support to TCR signalling.

  2016cites this paper
• Multiple sclerosis course and clinical outcomes in patients with comorbid asthma: a survey study

  2015cites this paper
• Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients.

  2015cites this paper
• Emerging and Evolving Topics in Multiple Sclerosis Pathogenesis and Treatments

  2015cites this paper
• Infection Risk in Patients on Multiple Sclerosis Therapeutics

  2015influential citation
• Helminth Therapy for MS.

  2015cites this paper
• miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis

  2015cites this paper
• Treg / Th 17 balance away from regulatory toward in fl ammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms

  2013cites this paper
• Helminth therapy and multiple sclerosis.

  2013cites this paper
• Influence of Peripheral inflammation on the progression of multiple sclerosis: evidence from the clinic and experimental animal models.

  2013cites this paper
• Molecular Biomarkers in Multiple Sclerosis

  2013cites this paper
• Special issue commentary: the changing face of inflammation in the brain.

  2013cites this paper
• Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms.

  2013cites this paper
• Progress in multiple sclerosis research in the last year

  2012cites this paper
• CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved.

  2012cites this paper
• Upregulation of IL-17, but not of IL-9, in circulating cells of CIS and relapsing MS patients. Impact of corticosteroid therapy on the cytokine network.

  2012cites this paper
• Vitamin D and Autoimmune Disease

  2012cites this paper